Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34<sup>pos</sup> Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction

<div>Antigen phenotype, proliferation rate, and functional characterization of hiPSC-MSCs. (a) Immunophenotype of the three hiPS-MSCs lines generated. Representative flow cytometry analysis of hBM-MSCs, FLF-iPSC-MSCs (OSKM), FLF-iPSC-MSCs (OSNL), MSC-iPSC-MSCs (OSKM), and MSC-derived iPSC line MSC-related markers CD73, CD90, and CD105 and hematopoietic CD45, CD34, and CD19 were assessed (solid histogram). (b)<i> In vitro</i> cell growth, measured as cumulative population of hiPSC-MSCs and BM-MSCs derived from 3 different donors (LM02, LM05, and LM06).</div>

Stem Cells International

fig3

Figure 3

Figure 3: Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34<sup>pos</sup> Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction 

Figure 3 | Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34pos Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction 